Q2 EPS Forecast for Keros Therapeutics Lifted by Analyst
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – Stock analysts at HC Wainwright increased their Q2 2025 earnings per share estimates for shares of Keros Therapeutics in a research note issued on Thursday, May 8th. HC Wainwright analyst A. Fein now forecasts that the company will earn ($1.28) per share for the quarter, up from […]
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – Stock analysts at HC Wainwright increased their Q2 2025 earnings per share estimates for shares of Keros Therapeutics in a research note issued on Thursday, May 8th. HC Wainwright analyst A. Fein now forecasts that the company will earn ($1.28) per share for the quarter, up from […]
